Clinical Trials Directory

Trials / Completed

CompletedNCT01569711

Deep Brain Stimulation of Nucleus Accumbens for Chronic and Resistant Major Depressive Disorder

Preliminary Study Evaluating Deep Brain Stimulation of Nucleus Accumbens in Patients Suffering From Chronic and Resistant Major Depressive Disorder

Status
Completed
Phase
Study type
Observational
Enrollment
6 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Depression is a common, recurrent and disabling disorder. Among patients with a chronic course of the disease, 20 to 30% are resistant to antidepressant medications. Among those patients, 50% would not benefit from electroconvulsive therapy (ECT). For such patients, deep brain stimulation (DBS) of nucleus accumbens is considered.

Detailed description

Depression is a common (12-Month Prevalence in the general population: 6%), recurrent and disabling disorder. Among patients with a chronic course of the disease, 20 to 30% are resistant to antidepressant medications. Among those patients not responding favorably to antidepressant medications, 50% would not benefit from ECT. For such patients, surgical interventions have been proposed in the past. Many results support the hypothesis of a dysfunction of the functional loops between cortical and subcortical structures underlying the expression of depressive disorders. Thus, therapeutic intervention focusing on these loops, in patients with chronic depression resistant to treatment, should be an issue and could improve prognosis of these patients. As part of a maximal resistance to antidepressant drug, after failure of a series of bilateral ECT, a surgical functional intervention using DBS of nucleus accumbens is considered. This open-label trial proposes to assess feasibility, safety and efficacy of DBS of nucleus accumbens in patients with chronic depression.

Conditions

Interventions

TypeNameDescription
PROCEDUREDeep brain stimulation of nucleus accumbens* Day0 : surgical placement of electrodes * M1 : stimulation of nucleus accumbens * M5 : stimulation of nucleus accumbens or associative territory of caudate nucleus (if no response observed with nucleus accumbens stimulation)

Timeline

Start date
2009-02-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2012-04-03
Last updated
2015-05-27

Locations

10 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01569711. Inclusion in this directory is not an endorsement.